Prot #MK-8415-060-02: A Phase 3, Open-label, Multi-center, Single Arm Study to Assess Contraceptive Efficacy and Safety of the Etonogestrel (MK-8415) Implant During Extended Use From 3 Years After Insertion in Females 35 Years of Age or Younger

Project: Research project

Project Details

Effective start/end date3/9/213/9/24


  • DrugDev Inc. (Prot #MK-8415-060-02)
  • Merck Sharp & Dohme Corporation (Prot #MK-8415-060-02)